MedTrace Logo

Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est

NCT04366206 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 143

Last updated 2020-04-28

No results posted yet for this study

Summary

Healthcare centers treated several hundreds of patients with Covid-19 and prospectively gathered information in electronic format between March, 2020 to April, 2020. In the course of Covid-19 treatment, physicians employed several drugs, including hydroxychloroquine, azithromycin, lopinavir/ritonavir, tocilizumab, baricitinib, sarilumab, corticosteroids and systematic antibiotics (list is not exhaustive).

This cohort study aims to assess factors associated with clinical outcomes in patients hospitalized for Covid-19, by analyzing associations between treatments and outcomes.

All data are collected in electronical records during routine practice.

Conditions

Sponsors & Collaborators

  • Groupe Hospitalier Pitie-Salpetriere

    collaborator OTHER

  • Centre Hospitalier Intercommunal Robert Ballanger

    lead OTHER

Principal Investigators

  • Hélène Gros, MD · Robert Ballanger

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-14
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04366206 on ClinicalTrials.gov